Clinical Trial Update: Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update for Remodulin in pediatric pulmonary hypertension with single-ventricle physiology after Fontan surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Remodulin (treprostinil)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED